FT
PASG icon

Fiduciary Trust’s Passage Bio PASG Stock Holding History

Fiduciary Trust’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.4K Hold
10,750
– – ﹤0.01% 862
2025
Q4 		$127K Hold
10,750
– – ﹤0.01% 852
2025
Q3 		$86.3K Hold
10,750
– – ﹤0.01% 843
2025
Q2 		$86.1K Hold
10,750
– – ﹤0.01% 821
2025
Q1 		$75.9K Hold
10,750
– – ﹤0.01% 809
2024
Q4 		$122K Hold
10,750
– – ﹤0.01% 680
2024
Q3 		$151K Hold
10,750
– – ﹤0.01% 638
2024
Q2 		$171K Hold
10,750
– – ﹤0.01% 612
2024
Q1 		$290K Buy
10,750
+5,000
+87% +$120K ﹤0.01% 567
2023
Q4 		$116K Hold
5,750
– – ﹤0.01% 613
2023
Q3 		$75.7K Hold
5,750
– – ﹤0.01% 601
2023
Q2 		$108K Hold
5,750
– – ﹤0.01% 615
2023
Q1 		$110K Buy
5,750
+250
+5% +$6.78K ﹤0.01% 603
2022
Q4 		$152K Buy
5,500
+5,000
+1,000% +$126K ﹤0.01% 607
2022
Q3 		$13K Buy
+500
New +$19.7K ﹤0.01% 608

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fiduciary Trust's PASG Position: Q1 2026 in Review

Fiduciary Trust held its Passage Bio (PASG) position steady in Q1 2026 at 10,750 shares worth $84.4K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Fiduciary Trust first reported a position in PASG in Q3 2022 and has held it in 15 quarters since. The position peaked at $290K in Q1 2024. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Fiduciary Trust held 10,750 shares of Passage Bio worth $84.4K as of Q1 2026.
  • Fiduciary Trust left its Passage Bio share count unchanged in Q1 2026.
  • Passage Bio made up ﹤0.01% of Fiduciary Trust's portfolio in Q1 2026, its #862 holding.
  • Fiduciary Trust first reported a position in Passage Bio in Q3 2022 and has held it in 15 quarters since.
  • Fiduciary Trust's Passage Bio position peaked at $290K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.